Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytogenetics and cancer.

S R Wolman

    Archives of Pathology & Laboratory Medicine
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Chromosome abnormalities offer insights into tumor diagnosis and prognosis but are not essential for tumor development. These changes act as markers for critical gene alterations, facilitating rapid tumor evolution.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Loss of sequences on the short arm of chromosome 17 is a late event in squamous carcinoma of the cervix.

    Molecular pathology : MP·2001
    Same author

    Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells.

    Breast cancer research and treatment·2001
    Same author

    Molecular approaches to identification of tissue contamination in surgical pathology sections.

    The Journal of molecular diagnostics : JMD·2001
    Same author

    Significance of p53 mutations in patients with chronic lymphocytic leukemia: a sequential study of 30 patients.

    Cancer·2001
    Same author

    Research potential of a unique xenograft model of human proliferative breast disease.

    Breast cancer research and treatment·2000
    Same author

    Race and differences in breast cancer survival in a managed care population.

    Journal of the National Cancer Institute·1999
    Same journal

    Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

    Archives of pathology & laboratory medicine·2026
    Same journal

    Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

    Archives of pathology & laboratory medicine·2026
    Same journal

    Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

    Archives of pathology & laboratory medicine·2026
    Same journal

    Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

    Archives of pathology & laboratory medicine·2026
    Same journal

    Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

    Archives of pathology & laboratory medicine·2026
    Same journal

    In Reply.

    Archives of pathology & laboratory medicine·2026
    See all related articles

    Area of Science:

    • Oncology
    • Genetics
    • Cell Biology

    Background:

    • Chromosome abnormalities are frequently observed in human tumors.
    • Their presence can aid in tumor diagnosis and prognosis.
    • However, their necessity and timing in tumorigenesis are variable.

    Purpose of the Study:

    • To elucidate the role and significance of chromosome abnormalities in human tumors.
    • To understand the relationship between chromosomal events and underlying genetic changes.
    • To explore how chromosome aberrations contribute to tumor evolution.

    Main Methods:

    • Review of existing literature on chromosomal abnormalities in cancer.
    • Analysis of the timing and frequency of chromosomal aberrations in tumor development.

    Related Experiment Videos

  • Correlation of chromosomal changes with gene mutations and cellular evolution.

    • Main Results:

    • Diploid tumor cells demonstrate that chromosomal abnormalities are not strictly necessary for tumor formation.
    • The variable timing of chromosomal events suggests they are not primary drivers but rather consequences or facilitators.
    • Chromosome aberrations serve as effective markers for essential gene alterations.

    Conclusions:

    • Chromosome abnormalities are not essential for tumorigenesis but are valuable diagnostic and prognostic markers.
    • These aberrations act as indicators of underlying genetic alterations.
    • Their high frequency in tumors likely facilitates multiple gene changes and promotes rapid cellular evolution.